Rachid Izzar - 29 Jan 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Issuer symbol
BIIB
Transactions as of
29 Jan 2024
Transactions value $
$0
Form type
4
Filing time
31 Jan 2024, 17:31:59 UTC
Previous filing
05 Jul 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Performance Stock Unit Award $0 +1,370 $0 1,370 29 Jan 2024 Common Stock 1,370 $0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024.